The price of a legal eighth of cannabis flower in the United States ranges from $20 in Oregon to $65 in Illinois. That is not a typo. The same product category, in the same country, under the same federal prohibition, varies by more than 200% depending entirely on where you happen to live.

This pricing disparity is not a market inefficiency that will naturally correct. It is a structural feature of state-by-state legalization, driven by tax policy, licensing constraints, supply conditions, and the degree to which each state’s regulators have prioritized consumer access versus market control. Understanding why prices differ — and where they are heading — is essential for consumers navigating their local dispensary options, operators, and investors alike.

The Data

We compiled retail pricing data from dispensary menus, state regulatory filings, and wholesale market reports across all 24 states with operational adult-use cannabis programs as of February 2026. The interactive tool below lets you compare prices across states for different product categories.

The headline numbers tell a clear story: mature markets are cheap, new markets are expensive, and the convergence between the two is happening faster than most operators anticipated.

Oregon continues to hold the title. Average dispensary prices for an eighth of mid-tier flower sit between $18 and $24, with premium brands rarely exceeding $35. Oregon’s combination of low barriers to entry, abundant outdoor cultivation, and a price-competitive market culture has produced the lowest consumer prices in the country — and driven significant consolidation among cultivators who cannot sustain margins at these levels.

Colorado and Washington follow closely, with average eighths in the $25 to $32 range. Both states are well past the initial supply-demand imbalance that characterizes new markets, and competition among dispensaries has compressed retail margins to levels that would be familiar to operators in any mature retail category.

Michigan has been the surprise story of the past 18 months. Average flower prices have fallen nearly 40% since mid-2024, driven by a surge of cultivation licenses and processing capacity that has flooded the market. Wholesale flower prices in Michigan have dipped below $800 per pound in some transactions — approaching the production cost floor for indoor cultivation.

Illinois remains the most expensive major market, with average eighths of branded flower ranging from $55 to $65 at most Chicago-area dispensaries. The state’s deliberately limited licensing structure — designed to create a controlled market with fewer operators — has achieved its intended effect of maintaining high prices, though at the cost of persistent consumer complaints and a thriving illicit market that undercuts dispensaries by 50% or more.

New York presents a different kind of pricing anomaly. The state’s troubled rollout of its adult-use program, combined with ongoing litigation over licensing and the dominance of unlicensed shops, has created a two-tier market where legal dispensary prices ($50 to $60 per eighth) coexist with widespread unlicensed retail at $25 to $35.

New Jersey’s prices have moderated from their initial highs but remain above the national average at $45 to $55 for an eighth, reflecting limited competition and high operational costs in the Northeast market.

What Drives the Gaps

Three factors explain the vast majority of interstate price variation.

Licensing policy is the single largest determinant. States that restrict the number of cultivation and retail licenses — Illinois, Connecticut, New Jersey — maintain higher prices through artificial supply constraints. States with open or loosely capped licensing — Oregon, Michigan, Oklahoma — see prices fall rapidly as supply exceeds demand.

Tax structure adds a layer of cost that varies dramatically. California’s combined state and local cannabis taxes can exceed 40% of the retail price in some jurisdictions. Oregon’s 17% state tax, with no local add-on, is among the lowest. The interactive calculator below shows exactly how much of your purchase goes to taxes in each state.

Market maturity matters because new markets always start expensive. Cultivation infrastructure takes 12 to 18 months to reach full production, and the initial wave of consumers — often migrating from the illicit market — are less price-sensitive than the broader population that enters later. Every state that has legalized has followed the same price curve: high prices at launch, rapid declines over 18 to 36 months, then stabilization at a level determined by the structural factors above.

Where Prices Are Heading

The national trend is unmistakably downward. Average dispensary prices for flower have declined approximately 15% year-over-year for the past three years, and there is no structural reason for this trend to reverse. More states are entering the market, cultivation technology continues to improve, and consumers are increasingly price-conscious as novelty gives way to routine purchasing.

The floor appears to be in the $15 to $20 range for an eighth of mid-tier flower in the most competitive markets — roughly equivalent to the cost structure that Oregon has demonstrated is sustainable for operators with efficient production and modest retail footprints.

For operators in high-price markets, the message is clear: your pricing power is borrowed time. The question is not whether prices will come down, but how quickly — and whether your cost structure can survive the compression.

The Concentrate and Edible Picture

Flower is not the whole story. Concentrate and edible pricing follows different dynamics, with less state-to-state variation and stronger brand premiums.

Half-gram vape cartridges range from $20 in Oregon to $50 in Illinois, with most states clustered between $30 and $40. The cartridge market has consolidated around a handful of national and regional brands — STIIIZY, Select, Raw Garden — that maintain more consistent pricing than the fragmented flower market.

Edibles show the smallest price variation across states, with 100mg packages (the standard in most markets) ranging from $15 to $30. The commoditization of edible manufacturing — gummies in particular — has compressed margins faster than any other product category.